Development and external validation of a simple pre-biopsy risk stratification model for clinically significant prostate

Development and external validation of a simple pre-biopsy risk stratification model for clinically significant prostate cancer in men with PI-RADS 3 lesions: a multicenter transperineal biopsy study

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.